1. Home
  2. LXRX vs UPXI Comparison

LXRX vs UPXI Comparison

Compare LXRX & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • UPXI
  • Stock Information
  • Founded
  • LXRX 1995
  • UPXI 2018
  • Country
  • LXRX United States
  • UPXI United States
  • Employees
  • LXRX 103
  • UPXI N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • LXRX Health Care
  • UPXI Health Care
  • Exchange
  • LXRX Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • LXRX 388.6M
  • UPXI 339.4M
  • IPO Year
  • LXRX 2000
  • UPXI 2021
  • Fundamental
  • Price
  • LXRX $1.07
  • UPXI $4.60
  • Analyst Decision
  • LXRX Buy
  • UPXI
  • Analyst Count
  • LXRX 4
  • UPXI 0
  • Target Price
  • LXRX $3.67
  • UPXI N/A
  • AVG Volume (30 Days)
  • LXRX 3.5M
  • UPXI 13.0M
  • Earning Date
  • LXRX 08-06-2025
  • UPXI 05-16-2025
  • Dividend Yield
  • LXRX N/A
  • UPXI N/A
  • EPS Growth
  • LXRX N/A
  • UPXI N/A
  • EPS
  • LXRX N/A
  • UPXI N/A
  • Revenue
  • LXRX $31,213,000.00
  • UPXI $16,562,327.00
  • Revenue This Year
  • LXRX N/A
  • UPXI $299.03
  • Revenue Next Year
  • LXRX N/A
  • UPXI N/A
  • P/E Ratio
  • LXRX N/A
  • UPXI N/A
  • Revenue Growth
  • LXRX 1251.21
  • UPXI 1378.83
  • 52 Week Low
  • LXRX $0.28
  • UPXI $1.90
  • 52 Week High
  • LXRX $2.25
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 52.30
  • UPXI 39.24
  • Support Level
  • LXRX $1.00
  • UPXI $5.43
  • Resistance Level
  • LXRX $1.11
  • UPXI $6.50
  • Average True Range (ATR)
  • LXRX 0.10
  • UPXI 1.22
  • MACD
  • LXRX -0.03
  • UPXI -0.08
  • Stochastic Oscillator
  • LXRX 16.28
  • UPXI 4.59

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.

Share on Social Networks: